Medicine guide

LAMIVUDINA/TENOFOVIR DISOPROXILO CIPLA

As listed in the register: LAMIVUDINA/TENOFOVIR DISOPROXILO CIPLA 300 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

300 mg/245 mg · comprimido recubierto con película

  • Prescription only
  • Antibiotics, antivirals and antifungals taken into the body
Active substance
Lamivudina + tenofovir
Made by
Cipla Europe

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupAntibiotics, antivirals and antifungals taken into the bodyJ05AR12

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byCipla Europe
Active substanceLamivudina + tenofovir
Used inAntibiotics, antivirals and antifungals taken into the body
Strength300 mg/245 mg
Formcomprimido recubierto con película
ClassificationJ05AR12 · Antibiotics, antivirals and antifungals taken into the body
Routevía oral
MarketedNo — authorised but not currently marketed, according to the register
Name in the registerLAMIVUDINA/TENOFOVIR DISOPROXILO CIPLA 300 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Nº Registro83802

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.